Compound library / Blends
Community-named three-peptide joint/recovery blend combining Cartalax (20mg), BPC-157 (10mg) and TB-500 (10mg) for 40mg total. A Cartalax-forward variant of the "Wolverine" stack — Cartalax is a short bioregulatory peptide studied for cartilage and connective-tissue support, paired here with BPC-157 and TB-500 for healing and recovery.
| Category | Blends |
|---|---|
| Regulatory standing | No approved product cited |
| Typical route | Subcutaneous |
| Half-life | Mixed (see individual peptides) |
| Common dose range | Per product label; typically 1 vial reconstituted and split across 2–4 injections per week |
| Typical cycle length | 8–12 weeks |
BioHack Track models Thor Blend at a half-life of 8 hours, so every dose you log is decayed against that curve and the app shows estimated active levels — not just what you typed.
No FDA-approved product for this compound is cited on this page, and no approved human dose is quoted. Treat the range below as research and community practice rather than a prescribed dose.
Reconstitute the 40mg vial with ~2 mL bacteriostatic water for ~20mg/mL total. Each 0.1 mL draw then delivers ~1mg Cartalax and ~0.5mg each of BPC-157 and TB-500.
Store lyophilized powder cold; refrigerate after reconstitution and use within about 28 days.
Research compound — not FDA-approved; human data on this specific blend is limited. Composition and ratios vary by supplier — verify the exact components against the product label / COA before logging doses.
Track Thor Blend in BioHack Track. Half-life, dose range and route come pre-filled from this library — log a dose and the app counts your vial down, models what is in your system, and puts it on the same chart as your labs and body composition.
These open a search of each database for Thor Blend — they are not citations, and nothing here is evidence for any particular dose. The same links are in the app.
The half-life, route and dose range on this page are compiled from published pharmacokinetic literature, manufacturer and product monographs where one exists, and the ranges commonly reported in clinical and research use. They are kept as a range rather than a single figure because that is what the sources actually support — a half-life varies with route, formulation and the person.
These are not citations, and this page is not a review of the evidence. Where a number matters to you, follow the database links above and read the source. We say so plainly rather than dressing a compiled reference up as one.
Nothing on this page has been reviewed by a named clinician. It is a reference for people already tracking a protocol, not a recommendation to start one.
General reference compiled for use inside the app, not medical advice and not a recommendation to take anything. Dose ranges are what is commonly discussed, not a prescription. Talk to a qualified healthcare professional.